Table 131Median treatment ranking (with their 95% CrI) of all interventions in the network and the probability of being the best treatment for improving/limiting the decline of FEV1 % predicted in the long-term

Median (95% CrI) treatment rankProbability of being the best treatment (%)
Placebo4 (3–5)8.12%
NSAIDs3 (1–4)65.20%
Macrolide antibiotics5 (2–5)5.99%
Inhaled corticosteroids1 (1–5)7.82%
Oral corticosteroids2 (1–3)12.88%

From: 9, Pulmonary monitoring, assessment and management

Cover of Cystic Fibrosis
Cystic Fibrosis: Diagnosis and management.
NICE Guideline, No. 78.
National Guideline Alliance (UK).
Copyright © NICE 2017.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.